Kärppä M, Ning X, Galic M, et al, Reduction in the number of headache hours and days with fremanezumab in patients with migraine and documented inadequate response to 2-4 migraine preventive medications in the international, multicentre, randomised, placebo-controlled FOCUS study. 5th European Academy of Neurology (EAN) Congress, abstract EPO3096.
Neurodegeneratieve en psychiatrische aandoeningen in ALS-families
jul 2017 | Neuro-musculair